Skip to content

PIMCO Dynamic Income Strategy Fund PDX Share Repurchase Program, Remaining Authorized, Amount

Share Repurchase Program, Remaining Authorized, Amount at other companies

ICU Medical logo
ICU MedicalICUI

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$0+42.9%

Profitability

See full
Operating margin11.3%
Net margin9%
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by PIMCO Dynamic Income Strategy Fund in its filing.

Tagged under the XBRL concept us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1.

The official record: PIMCO Dynamic Income Strategy Fund’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about PIMCO Dynamic Income Strategy Fund's share repurchase program, remaining authorized, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PIMCO Dynamic Income Strategy Fund's share repurchase program, remaining authorized, amount?
PIMCO Dynamic Income Strategy Fund (PDX) reported share repurchase program, remaining authorized, amount of $146.3M in Q1 2026.
What is the long-term trend for PIMCO Dynamic Income Strategy Fund's share repurchase program, remaining authorized, amount?
Over 3 years (2020 to 2024), PIMCO Dynamic Income Strategy Fund's share repurchase program, remaining authorized, amount has grown at a -69.1% compound annual growth rate (CAGR), from $98.7M to $2.9M.